• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tg Therapeutics (NQ: TGTX )

    27.17 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Tg Therapeutics

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
    The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product. 
    Via Investor's Business Daily
    Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    10 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts
    Via Benzinga
    Delving into NASDAQ:TGTX's Growth Prospects.
    Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock. 
    Via Chartmill
    Why NASDAQ:TGTX qualifies as a high growth stock.
    Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing? 
    Via Chartmill
    AI Stocks Meta, Oracle Lead Five Names Near Buy Points
    Two of the 5 top stocks to watch this week tap the artificial intelligence market. 
    Via Investor's Business Daily
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
    Amid the election, and a Fed rate vote, earnings season roars ahead. 
    Via Investor's Business Daily
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX.
    TG THERAPEUTICS INC (NASDAQ:TGTX) stands out as a growth opportunity that won't break the bank. 
    Via Chartmill
    NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
    TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
    Via Chartmill
    For those who appreciate growth without the sticker shock, NASDAQ:TGTX is worth considering.
    NASDAQ:TGTX is showing decent growth, but is still valued reasonably. 
    Via Chartmill
    Unlocking the Growth Potential of NASDAQ:TGTX.
    TG THERAPEUTICS INC (NASDAQ:TGTX) may be suited for growth investing, we'll explore why in this article. 
    Via Chartmill
    Evaluating TG Therapeutics: Insights From 4 Financial Analysts
    Via Benzinga
    What's Going On With TG Therapeutics Stock Wednesday?
    TG Therapeutics announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials. 
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review
    TheApple iPhone 16 went on sale amid mixed signals about demand. 
    Via Investor's Business Daily
    Topics Economy
    Exposures Interest Rates
    IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
    The company unveiled five-year test results for its multiple sclerosis drug, Briumvi. 
    Via Investor's Business Daily
    Despite its growth, NASDAQ:TGTX remains within the realm of affordability.
    While growth is established for TG THERAPEUTICS INC (NASDAQ:TGTX), the stock's valuation remains reasonable. 
    Via Chartmill
    NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
    TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
    Via Chartmill
    Why NASDAQ:TGTX is Poised for High Growth.
    Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics. 
    Via Chartmill
    In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
    NASDAQ:TGTX, a growth stock which is not overvalued. 
    Via Chartmill
    Decoding TG Therapeutics's Options Activity: What's the Big Picture?
    Via Benzinga
    What's Going On With ADMA Biologics Stock Monday?
    ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
    The company reported a surprise profit in the second quarter, vs. expectations for losses. 
    Via Investor's Business Daily
    ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Why the growth investor may take a look at NASDAQ:TGTX.
    Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing? 
    Via Chartmill
    A Closer Look at TG Therapeutics's Options Market Dynamics
    Via Benzinga
    NASDAQ:TGTX: a strong growth stock preparing for the next leg up?.
    TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating. 
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.